STXS Stereotaxis Inc.

AMEX
$1.30

Stereotaxis Inc. (STXS) is expected to report earnings on November 11, 2026, after the market close. The stock has had a Post-Earnings Announcement Drift (PEAD) of -13.3% since its last earnings release on August 11, 2026.

Stereotaxis Missed Consensus Estimates
Tuesday, August 11, 2026 · 4:01 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 11
Wednesday · 4:00 PM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $1.37

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Stereotaxis Inc.

Stereotaxis is the global leader in innovative robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures.

Sector

Healthcare

Industry

Medical Appliances/Equipment

Held By 2 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.